| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Kei Odai, Tohru Sugimoto, Etsuro It. Biophysics and physicobiology. vol 16. 2020-09-30. PMID:31608202. |
5-hydroxytryptamine (5-ht; serotonin) regulates metabolism and various homeostatic mechanisms in the body, and is involved in depression. |
2020-09-30 |
2023-08-13 |
Not clear |
| Hye-Geum Kim, Bon-Hoon Koo, Seung Woo Lee, Eun-Jin Cheo. Apathy syndrome in a patient previously treated with selective serotonin reuptake inhibitors for depression. Yeungnam University journal of medicine. vol 36. issue 3. 2020-09-30. PMID:31620640. |
apathy syndrome in a patient previously treated with selective serotonin reuptake inhibitors for depression. |
2020-09-30 |
2023-08-13 |
Not clear |
| Hye-Geum Kim, Bon-Hoon Koo, Seung Woo Lee, Eun-Jin Cheo. Apathy syndrome in a patient previously treated with selective serotonin reuptake inhibitors for depression. Yeungnam University journal of medicine. vol 36. issue 3. 2020-09-30. PMID:31620640. |
in this report, we present the case of a 67-year-old woman with a history of receiving selective serotonin reuptake inhibitor (ssri) treatment for depression. |
2020-09-30 |
2023-08-13 |
Not clear |
| Yong Soo Park, Ki-Wug Sun. Selective serotonin reuptake inhibitor escitalopram inhibits 5-HT The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology. vol 23. issue 6. 2020-09-30. PMID:31680773. |
as an s-enantiomer of citalopram, it shows better therapeutic outcome in depression and anxiety disorder treatment because it has higher selectivity for serotonin reuptake transporter than citalopram. |
2020-09-30 |
2023-08-13 |
Not clear |
| Jun Zhao, Huiling Tian, Hongtao Song, Xu Wang, Tong Luo, Liya Ai, Yumin Fang, Jianghao Zhao, Saiyin Chao-Ke-Tu, Zhigang L. Effect of Electroacupuncture on Reuptake of Serotonin via miRNA-16 Expression in a Rat Model of Depression. Evidence-based complementary and alternative medicine : eCAM. vol 2019. 2020-09-30. PMID:31929820. |
effect of electroacupuncture on reuptake of serotonin via mirna-16 expression in a rat model of depression. |
2020-09-30 |
2023-08-13 |
rat |
| b' Lidia Bravo, Meritxell Llorca-Torralba, Esther Berrocoso, Juan Antonio Mic\\xc3\\xb. Monoamines as Drug Targets in Chronic Pain: Focusing on Neuropathic Pain. Frontiers in neuroscience. vol 13. 2020-09-30. PMID:31942167.' |
accordingly, drugs that modulate the monaminergic system and that were originally designed to treat depression are now considered to be first line treatments for certain types of neuropathic pain (e.g., serotonin and noradrenaline (and also dopamine) reuptake inhibitors). |
2020-09-30 |
2023-08-13 |
Not clear |
| Jonathan M Gregory, Joshua D Rosenblat, Roger S McIntyr. Deconstructing Diabetes and Depression: Clinical Context, Treatment Strategies, and New Directions. Focus (American Psychiatric Publishing). vol 14. issue 2. 2020-09-30. PMID:31975802. |
selective serotonin reuptake inhibitors effectively treat depression of patients with diabetes and positively influence glycemic control. |
2020-09-30 |
2023-08-13 |
Not clear |
| Randall S. Stafford, Ellen A. MacDonald, Stan N. Finkelstei. National Patterns of Medication Treatment for Depression, 1987 to 2001. Primary care companion to the Journal of clinical psychiatry. vol 3. issue 6. 2020-09-29. PMID:15014590. |
background: we investigated trends in antidepressant use, as well as broader changes in depression treatment, following the availability of selective serotonin reuptake inhibitors (ssris). |
2020-09-29 |
2023-08-12 |
Not clear |
| Patricia A. Marken, J Stuart Munr. Selecting a Selective Serotonin Reuptake Inhibitor: Clinically Important Distinguishing Features. Primary care companion to the Journal of clinical psychiatry. vol 2. issue 6. 2020-09-29. PMID:15014630. |
selective serotonin reuptake inhibitors (ssris) are widely prescribed to treat depression. |
2020-09-29 |
2023-08-12 |
Not clear |
| Randall S. Stafford, John C. Ausiello, Bismruta Misra, Demet Sagla. National Patterns of Depression Treatment in Primary Care. Primary care companion to the Journal of clinical psychiatry. vol 2. issue 6. 2020-09-29. PMID:15014631. |
among specific antidepressants, selective serotonin reuptake inhibitors were most often prescribed by primary care physicians (26% of depression visits). |
2020-09-29 |
2023-08-12 |
Not clear |
| Randall S. Stafford, John C. Ausiello, Bismruta Misra, Demet Sagla. National Patterns of Depression Treatment in Primary Care. Primary care companion to the Journal of clinical psychiatry. vol 2. issue 6. 2020-09-29. PMID:15014631. |
conclusion: the predominant use of selective serotonin reuptake inhibitors suggests that primary care physicians have begun to adopt new therapeutic strategies for depression. |
2020-09-29 |
2023-08-12 |
Not clear |
| Larry Culpeppe. Escitalopram: A New SSRI for the Treatment of Depression in Primary Care. Primary care companion to the Journal of clinical psychiatry. vol 4. issue 6. 2020-09-29. PMID:15014711. |
escitalopram is the s-enantiomer of the racemic compound citalopram, a selective serotonin reuptake inhibitor (ssri) widely used for the treatment of depression. |
2020-09-29 |
2023-08-12 |
Not clear |
| Craig H. Mallinckrodt, David J. Goldstein, Michael J. Detke, Yili Lu, John G. Watkin, Pierre V. Tra. Duloxetine: A New Treatment for the Emotional and Physical Symptoms of Depression. Primary care companion to the Journal of clinical psychiatry. vol 5. issue 1. 2020-09-29. PMID:15156243. |
duloxetine, a dual-reuptake inhibitor of serotonin and norepinephrine, may have a positive effect on physical symptoms in addition to efficacy in treating emotional symptoms of depression. |
2020-09-29 |
2023-08-12 |
Not clear |
| Paul A. Pirraglia, Randall S. Stafford, Daniel E. Singe. Trends in Prescribing of Selective Serotonin Reuptake Inhibitors and Other Newer Antidepressant Agents in Adult Primary Care. Primary care companion to the Journal of clinical psychiatry. vol 5. issue 4. 2020-09-29. PMID:15213776. |
background: the introduction of selective serotonin reuptake inhibitors (ssris) represented a breakthrough in depression treatment due to their safety and ease of use. |
2020-09-29 |
2023-08-12 |
Not clear |
| Timothy R. Beriga. Atomoxetine Used Adjunctively With Selective Serotonin Reuptake Inhibitors to Treat Depression. Primary care companion to the Journal of clinical psychiatry. vol 6. issue 2. 2020-09-29. PMID:15254604. |
atomoxetine used adjunctively with selective serotonin reuptake inhibitors to treat depression. |
2020-09-29 |
2023-08-12 |
Not clear |
| Andy R Eugene, Jolanta Masiak, Marek Masiak, Jacek Kapic. Isolating the Norepinephrine Pathway Comparing Lithium in Bipolar Patients to SSRIs in Depressive Patients. Brain : broad research in artificial intelligence and neuroscience. vol 5. issue 1-4. 2020-09-29. PMID:26609422. |
to accomplish this, we compared patients with bipolar disorder treated with lithium to patients diagnosed with major depression or depressive disorder who are treated with selective serotonin reuptake inhibitors (ssris). |
2020-09-29 |
2023-08-13 |
Not clear |
| Mario F Juruena, Bruno Agustini, Anthony J Cleare, Allan H Youn. A translational approach to clinical practice via stress-responsive glucocorticoid receptor signaling. Stem cell investigation. vol 4. 2020-09-29. PMID:28275643. |
also serotonin and hpa axis dysfunctions have already been implicated in a variety of psychiatric disorders, especially depression. |
2020-09-29 |
2023-08-13 |
human |
| Diana Lupu, Marcus O D Sjödin, Mukesh Varshney, Johan Lindberg, Felicia Loghin, Joëlle Rüeg. Fluoxetine modulates sex steroid levels in vitro. Clujul medical (1957). vol 90. issue 4. 2020-09-29. PMID:29151792. |
selective serotonin reuptake inhibitors (ssris) are antidepressants increasingly prescribed against depression during and after pregnancy. |
2020-09-29 |
2023-08-13 |
Not clear |
| Zhuoyuan Zhong, Limin Wang, Xiaojun Wen, Yunyun Liu, Yafei Fan, Zhonglin Li. A meta-analysis of effects of selective serotonin reuptake inhibitors on blood pressure in depression treatment: outcomes from placebo and serotonin and noradrenaline reuptake inhibitor controlled trials. Neuropsychiatric disease and treatment. vol 13. 2020-09-29. PMID:29158677. |
a meta-analysis of effects of selective serotonin reuptake inhibitors on blood pressure in depression treatment: outcomes from placebo and serotonin and noradrenaline reuptake inhibitor controlled trials. |
2020-09-29 |
2023-08-13 |
Not clear |
| Zhuoyuan Zhong, Limin Wang, Xiaojun Wen, Yunyun Liu, Yafei Fan, Zhonglin Li. A meta-analysis of effects of selective serotonin reuptake inhibitors on blood pressure in depression treatment: outcomes from placebo and serotonin and noradrenaline reuptake inhibitor controlled trials. Neuropsychiatric disease and treatment. vol 13. 2020-09-29. PMID:29158677. |
selective serotonin reuptake inhibitors (ssris) and serotonin and noradrenaline reuptake inhibitors (snris) have been commonly prescribed for depression treatment. |
2020-09-29 |
2023-08-13 |
Not clear |